The long-term investor command center. One ticker, the whole case — a Quality / Value / Momentum / Smart-Money read on top of valuation-in-context, ROIC & moat, dividend health, trend, financial health, and who’s buying. Built only from SEC filings and end-of-day prices. Glass-box, no invented numbers.
Building GYRE’s long-term case…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
GYRE Dashboard — GYRE THERAPEUTICS, INC. | StockTools.ai
GYRE
Gyre Therapeutics, Inc.Small cap · $557.9M · FY ending 2025-12-31
P/E vs its last 12 months (our price history): 278.0 low → 443.5 high
Current price sits at the 6th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.